AlphaMadera's AlphaVal page computes Viemed Healthcare, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag VMD as undervalued, fairly valued, or overvalued.

What is Viemed Healthcare, Inc.'s fair value?

Fair value for VMD is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value VMD?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from VMD's most recent reported fundamentals.

VMD - Viemed Healthcare, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong

Trading 126.2% above fair value

Current Price $9.65

Bear Case $2.65 72.5% downside ($2.65 - $9.65) / $9.65 = -72.5% 9% stage 1 growth, 11% discount

Fair Value $4.27 55.8% downside ($4.27 - $9.65) / $9.65 = -55.8% 16% stage 1 growth, 11% discount

Bull Case $6.09 36.9% downside ($6.09 - $9.65) / $9.65 = -36.9% 20% stage 1 growth, 11% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

15.5%

Discount Rate (WACC)

11.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (16% base case)

Terminal Value % of EV 43%

Implied Market Multiple 73.3x

Plain-Language Summary

Using a two-stage FCF DCF with 16% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $4.27 per share.

Warnings

⚠ Stock-based employee pay equals 61% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions